Press release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio
One document
more
Stories about Pharmakologie
Biomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
more- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
One documentmore - 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
One documentmore Potentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
more
New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
morePress release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
One documentmoreJanneke van der Kamp starts as new Chief Commercial Officer at Grünenthal
more
Switching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signaling
moreThe New Era Biotechnology Co., Ltd.
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)
moreCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
more- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
One documentmore New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
more- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore
- 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore - 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore Hitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe (HMSE): The new "Plus" in human-centered open MRI is taking off at ECR 2021 with "SynergyDrive", the suite for streamlined workflow and high-speed exams
more- 2
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
more Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
One documentmoreEuropean Society for Medical Oncology (ESMO)
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research
more
- 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
more- 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
One documentmore Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
moreRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
moreKOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB
One documentmore
Previous123Next